Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway
Ademola Adetokunbo Oyagbemi, Temidayo Olutayo Omóbòwálé, Olumuyiwa Abiola Adejumobi, Abiodun Mary Owolabi, Blessing Seun Ogunpolu, Olufunke Olubunmi Falayi, Fasilat Oluwakemi Hassan, Iyanuoluwa Omolola Ogunmiluyi, Ebunoluwa Racheal Asenuga, Olufunke Eunice Ola‐Davies, K. O. Soetan, Adebowale Benard Saba, Adeolu Alex Adedapo, Sanah Malomile Nkadimeng, Lyndy J. McGaw, Oluwafemi Omoniyi Oguntibeju, Momoh Audu Yakubu
Topics & Concepts
Mineralocorticoid receptorEndocrinologyInternal medicineLisinoprilNaringeninCreatinineKidneyBlood urea nitrogenMedicineAngiotensin-converting enzymeChemistryBlood pressurePharmacologyAldosteroneBiochemistryFlavonoidAntioxidantHormonal Regulation and HypertensionBlood Pressure and Hypertension StudiesSodium Intake and Health